These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29318971)

  • 1. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Becker RE; Greig NH; Lahiri DK; Bledsoe J; Majercik S; Ballard C; Aarsland D; Schneider LS; Flanagan D; Govindarajan R; Sano M; Ferrucci L; Kapogiannis D
    Curr Alzheimer Res; 2018; 15(9):883-891. PubMed ID: 29318971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?
    Becker RE; Kapogiannis D; Greig NH
    Alzheimers Dement; 2018 Apr; 14(4):431-443. PubMed ID: 29245000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.
    Lecca D; Bader M; Tweedie D; Hoffman AF; Jung YJ; Hsueh SC; Hoffer BJ; Becker RE; Pick CG; Lupica CR; Greig NH
    Neurobiol Dis; 2019 Oct; 130():104528. PubMed ID: 31295555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
    Greig NH; Sambamurti K; Yu QS; Brossi A; Bruinsma GB; Lahiri DK
    Curr Alzheimer Res; 2005 Jul; 2(3):281-90. PubMed ID: 15974893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Was phenserine a failure or were investigators mislead by methods?
    Becker RE; Greig NH
    Curr Alzheimer Res; 2012 Dec; 9(10):1174-81. PubMed ID: 23227991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?
    Becker RE; Greig NH
    Alzheimers Dement; 2013 Jan; 9(1):50-7. PubMed ID: 22465172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
    Greig NH; Lecca D; Hsueh SC; Nogueras-Ortiz C; Kapogiannis D; Tweedie D; Glotfelty EJ; Becker RE; Chiang YH; Hoffer BJ
    CNS Neurosci Ther; 2020 Jun; 26(6):636-649. PubMed ID: 31828969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
    Hoffer BJ; Pick CG; Hoffer ME; Becker RE; Chiang YH; Greig NH
    J Biomed Sci; 2017 Sep; 24(1):71. PubMed ID: 28886718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.
    Tweedie D; Fukui K; Li Y; Yu QS; Barak S; Tamargo IA; Rubovitch V; Holloway HW; Lehrmann E; Wood WH; Zhang Y; Becker KG; Perez E; Van Praag H; Luo Y; Hoffer BJ; Becker RE; Pick CG; Greig NH
    PLoS One; 2016; 11(6):e0156493. PubMed ID: 27254111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenserine efficacy in Alzheimer's disease.
    Winblad B; Giacobini E; Frölich L; Friedhoff LT; Bruinsma G; Becker RE; Greig NH
    J Alzheimers Dis; 2010; 22(4):1201-8. PubMed ID: 20930279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenserine Axonyx.
    Thatte U
    Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
    Greig NH; De Micheli E; Holloway HW; Yu QS; Utsuki T; Perry TA; Brossi A; Ingram DK; Deutsch J; Lahiri DK; Soncrant TT
    Acta Neurol Scand Suppl; 2000; 176():74-84. PubMed ID: 11261809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine.
    Marutle A; Ohmitsu M; Nilbratt M; Greig NH; Nordberg A; Sugaya K
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12506-11. PubMed ID: 17640880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
    Greig NH; Pei XF; Soncrant TT; Ingram DK; Brossi A
    Med Res Rev; 1995 Jan; 15(1):3-31. PubMed ID: 7898167
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
    Kadir A; Andreasen N; Almkvist O; Wall A; Forsberg A; Engler H; Hagman G; Lärksäter M; Winblad B; Zetterberg H; Blennow K; Långström B; Nordberg A
    Ann Neurol; 2008 May; 63(5):621-31. PubMed ID: 18300284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
    Nordberg A; Kadir A; Andreasen N; Almkvist O; Wall A; Långström B; Zetterberg H
    J Alzheimers Dis; 2015; 47(3):691-704. PubMed ID: 26401704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenserine.
    Klein J
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1087-97. PubMed ID: 17594192
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.